As of 2025-07-04, the Intrinsic Value of SANUWAVE Health Inc (SNWV) is 2.84 USD. This SNWV valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 31.65 USD, the upside of SANUWAVE Health Inc is -91.00%.
The range of the Intrinsic Value is 0.60 - 10.52 USD
Based on its market price of 31.65 USD and our intrinsic valuation, SANUWAVE Health Inc (SNWV) is overvalued by 91.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (2.64) - (0.43) | (2.15) | -106.8% |
| DCF (Growth 10y) | 0.60 - 10.52 | 2.84 | -91.0% |
| DCF (EBITDA 5y) | 0.58 - 1.59 | 1.07 | -96.6% |
| DCF (EBITDA 10y) | 5.09 - 7.88 | 6.41 | -79.8% |
| Fair Value | -0.23 - -0.23 | -0.23 | -100.72% |
| P/E | (0.77) - (0.31) | (0.61) | -101.9% |
| EV/EBITDA | 14.39 - 23.73 | 19.51 | -38.4% |
| EPV | (12.74) - (15.10) | (13.92) | -144.0% |
| DDM - Stable | (0.69) - (3.90) | (2.29) | -107.2% |
| DDM - Multi | (86.52) - (377.76) | (140.29) | -543.2% |
| Market Cap (mil) | 270.92 |
| Beta | 1.23 |
| Outstanding shares (mil) | 8.56 |
| Enterprise Value (mil) | 300.25 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.84% |
| Cost of Debt | 11.31% |
| WACC | 7.31% |